| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |